BeStock  
Stocks › ACAD

ACADIA Pharmaceuticals ACAD

US equityMarket cap rank #2381
$20.11 +$0.16 (+0.80%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $20.25 +0.70%
Open$20.05
Prev close$19.95
Day range$19.57 – $20.45
Volume3.15M
Market cap$3.47B
P/E (TTM)9.0
Dividend yield–

ACAD Stock News

Headlines matching ACADIA Pharmaceuticals or the ACAD ticker, most recent first.

  • CCORF Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $36Market news · 3 Sep 2026
  • A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $31 to $36Market news · 26 Sep 2026
  • Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Kyverna Therapeutics, Inc. (KYTX)TipRanks · 25 Sep 2026
  • Analysts' Top Healthcare Picks: Kyverna Therapeutics, Inc. (KYTX), ACADIA Pharmaceuticals (ACAD)TipRanks · 25 Sep 2026
  • Morgan Stanley Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Maintains Target Price $26Market news · 5 Aug 2026
  • BofA Securities Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $31Market news · 5 Aug 2026
  • A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $36 to $38Market news · 5 Aug 2026
  • RBC Capital Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $37Market news · 5 Aug 2026
  • Deutsche Bank Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $38Market news · 25 Aug 2026
  • A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $36 to $40Market news · 25 Aug 2026
  • BMO Capital Initiates ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Announces Target Price $36Market news · 18 Aug 2026
  • UBS Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $49Market news · 18 Aug 2026
  • UBS Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $49Market news · 17 Aug 2026
  • Needham Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $41Market news · 12 Aug 2026
  • Citi Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $39Market news · 10 Aug 2026

Discussion

No comments yet — be the first to weigh in on ACAD.

Leave a comment

Scroll to Top